HC Wainwright & Co. Reiterates Milestone Pharmaceuticals (MIST) Buy Recommendation
Fintel reports that on May 15, 2023, HC Wainwright & Co. reiterated coverage of Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy recommendation.
Symbol | Last Price | Change | % Change |
---|---|---|---|